Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Novanta Inc. (NOVT) Stock Forecast & Price Prediction United States | NASDAQ | Technology | Scientific & Technical Instruments
$105.45
-1.81 (-1.69%)Did NOVT Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Novanta is one of their latest high-conviction picks.
Based on our analysis of 3 Wall Street analysts, NOVT has a bullish consensus with a median price target of $141.50 (ranging from $133.00 to $150.00). The overall analyst rating is Strong Buy (9.0/10). Currently trading at $105.45, the median forecast implies a 34.2% upside. This outlook is supported by 2 Buy, 0 Hold, and 0 Sell ratings.
Conversely, the most conservative target is provided by Robert Mason at Baird, suggesting a 26.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for NOVT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 11, 2025 | Baird | Robert Mason | Neutral | Maintains | $133.00 |
| Mar 3, 2025 | Baird | Robert Mason | Neutral | Maintains | $160.00 |
| Nov 6, 2024 | Baird | Robert Mason | Neutral | Maintains | $169.00 |
| Aug 7, 2024 | Baird | Robert Mason | Neutral | Maintains | $175.00 |
| May 11, 2023 | Baird | Robert Mason | Neutral | Maintains | $161.00 |
| May 11, 2022 | William Blair | Brian Drab | Outperform | Upgrade | $N/A |
| Nov 13, 2020 | Berenberg | Hold | Initiates | $N/A | |
| May 13, 2020 | Baird | Neutral | Maintains | $90.00 | |
| Feb 28, 2019 | Baird | Neutral | Maintains | $81.00 | |
| May 9, 2018 | Baird | Neutral | Downgrade | $N/A | |
| Feb 27, 2018 | William Blair | Outperform | Initiates | $N/A | |
| Dec 8, 2017 | Baird | Outperform | Initiates | $N/A |
The following stocks are similar to Novanta based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Novanta Inc. has a market capitalization of $3.79B with a P/E ratio of 72.2x. The company generates $960.31M in trailing twelve-month revenue with a 5.5% profit margin.
Revenue growth is +1.4% quarter-over-quarter, while maintaining an operating margin of +11.5% and return on equity of +6.8%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Designs and manufactures precision photonic components.
Novanta Inc. generates revenue by designing, manufacturing, and selling precision photonic and motion control components and subsystems. Their products are sold to various industries, including healthcare and advanced technologies, where they enhance precision and quality in production processes.
The company is known for its innovation-driven approach and commitment to quality, ensuring compliance with strict industry standards. Based in Bedford, Massachusetts, Novanta has a global presence, allowing it to cater to a diverse international clientele and play a critical role in sophisticated manufacturing.
Technology
Scientific & Technical Instruments
3,000
Mr. Matthijs Glastra
United States
1999
Novanta (NOVT) delivered earnings and revenue surprises of +7.41% and +0.85%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Fabrinet (FN) delivered earnings and revenue surprises of +3.18% and +4.48%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
OSI (OSIS) delivered earnings and revenue surprises of +3.65% and +2.11%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Novanta Inc. has launched a public offering of 11 million tangible equity units, totaling $550 million. Each unit is priced at $50 and includes a prepaid stock purchase contract and a senior amortizing note due 2028.
Novanta's public offering of 11 million tangible equity units raises $550 million, impacting its capital structure and potential growth opportunities, influencing investor sentiment and stock valuation.
Novanta Inc. has priced a public offering of 11 million tangible equity units at $50 each, totaling $550 million, under its effective shelf registration statement.
Novanta's pricing of 11 million equity units at $50 each indicates confidence in its financial health, potentially enhancing liquidity and funding for growth, impacting stock performance and investor sentiment.
Novanta Inc. (NOVT) will hold its Q3 2025 earnings call on November 4, 2025, at 8:30 AM EST, featuring CEO Matthijs Glastra and CFO Robert Buckley.
Novanta Inc.'s upcoming Q3 earnings call may reveal financial performance insights, guidance updates, and strategic initiatives, influencing stock sentiment and investment decisions.
Novanta Inc. (NASDAQ: NOVT) reported Q3 2025 revenue of $247.8M, up from $244.4M in Q3 2024. Operating income decreased to $21.8M, net income to $10.7M, with diluted EPS at $0.30.
Novanta's Q3 results show revenue growth but declining operating income and net income, indicating potential profitability concerns that may affect investor confidence and stock performance.
Novanta (NOVT) reported Q3 earnings of $0.87 per share, exceeding the Zacks estimate of $0.81 and up from $0.85 per share year-over-year.
Novanta's earnings beat expectations, signaling strong performance and potential growth, which may boost investor confidence and affect stock price positively.
Novanta (NOVT) saw increased trading volume recently, but recent earnings estimate revisions may hinder its upward momentum in the near term.
Novanta's increased trading volume signals heightened investor interest, but negative earnings estimate revisions could hinder future stock performance, impacting investment decisions.
Based on our analysis of 3 Wall Street analysts, Novanta Inc. (NOVT) has a median price target of $141.50. The highest price target is $150.00 and the lowest is $133.00.
According to current analyst ratings, NOVT has 2 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $105.45. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict NOVT stock could reach $141.50 in the next 12 months. This represents a 34.2% increase from the current price of $105.45. Please note that this is a projection by Wall Street analysts and not a guarantee.
Novanta Inc. generates revenue by designing, manufacturing, and selling precision photonic and motion control components and subsystems. Their products are sold to various industries, including healthcare and advanced technologies, where they enhance precision and quality in production processes.
The highest price target for NOVT is $150.00 from at , which represents a 42.2% increase from the current price of $105.45.
The lowest price target for NOVT is $133.00 from Robert Mason at Baird, which represents a 26.1% increase from the current price of $105.45.
The overall analyst consensus for NOVT is bullish. Out of 3 Wall Street analysts, 2 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $141.50.
Stock price projections, including those for Novanta Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.